CRUCIBLE THERAPEUTICS LIMITED - Profile & Financials

Accounts Submitted 7 Nov 2025

Confirmation Statement Submitted 17 Apr 2025

Net assets £2.46M

Total assets £2.68M

Total Liabilities £228.10K

Charges None No charges registered

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

The Innovation Centre 217 Portobello Sheffield S1 4DP England

Credit Report

Discover CRUCIBLE THERAPEUTICS LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2024–2024)

Cash in Bank

£2.56M

Net Assets

£2.46M

Total Liabilities

£228.10k

Turnover

N/A

Employees

Debt Ratio

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End
P&L
Revenue	£142.3M
Gross Profit	£48.2M
Operating Profit	£22.4M
Net Profit	£18.1M
EBITDA	£31.5M
Assets
Cash	£24.7M
Total Assets	£89.4M
Liabilities
Total Liabilities	£45.2M
Key Metrics
Employees	1,247

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share allotments and capital structure

4 Allotments 21,500 Shares £5.00m Total

Date From	Share Class	Shares Allotted	Amount Raised	Price/Share
10 Mar 2025	SEED	8,000	£2.00m	£250
14 Feb 2024	SEED	8,000	£2.00m	£250
21 Sept 2023	SEED	4,000	£1.00m	£250
20 Sept 2023	ORDINARY	1,500	£0.15	£0

Officers

6 active 2 resigned

Show resigned officers

						Status
Guillaume Marcel Pierre Hautbergue	Director	French	England	53	27 Feb 2023	Active
James Gibbons	Director	British	England	36	17 Oct 2024	Active
Jonathan Foley	Director	Canadian,british	England	44	21 Sept 2023	Active
Juliet Maria Livadiotis	Director	Cypriot	England	45	21 Sept 2023	Active
Neill Moray Mackenzie	Director	British	England	72	21 Sept 2023	Active
Samantha Jane Macro	Secretary	Unknown	Unknown	—	23 Jul 2025	Active

Shareholders

Shareholders (8)


The University Of Sheffield	7.1%	2,125	Ordinary	17 Apr 2025
Pamela Shaw	5.4%	1,625	Ordinary	17 Apr 2025
Northern Gritstone Limited	5.0%	1,500	Ordinary	17 Apr 2025

Persons with Significant Control

Persons with Significant Control (2)

2 Active 1 Ceased

Argobio S.a.s.

France

Active

Notified 14 Feb 2024

Nature of Control

Ownership Of Shares 25 To 50 Percent
Voting Rights 25 To 50 Percent

Northern Gritstone Limited

United Kingdom

Active

Notified 14 Feb 2024

Nature of Control

Ownership Of Shares 25 To 50 Percent
Voting Rights 25 To 50 Percent

Professor Guillaume Marcel Pierre Hautbergue

Ceased 21 Sept 2023

Ceased

See All Controllers

Group Structure

ARGOBIO S.A.S. france

NORTHERN GRITSTONE LIMITED united kingdom

CRUCIBLE THERAPEUTICS LIMITED Current Company

Charges

No charges registered

Documents

Company Filings

Date	Category	Description	Document
7 Nov 2025	Accounts	Annual accounts made up to 2025-02-28	View(6 pages)
14 Aug 2025	Officers	Appointment of Dr Samantha Jane Macro as director on 2025-07-23	View(2 pages)
14 Aug 2025	Officers	Termination of Ross Alexander Mcmaster as director on 2025-07-23	View(1 page)
17 Apr 2025	Confirmation Statement	Confirmation statement made on 2025-04-05 with updates	View(4 pages)
17 Apr 2025	Capital	Allotment of shares (GBP 3) on 2025-03-10	View(3 pages)